Form 8-K - Current report:
SEC Accession No. 0000950170-24-096127
Filing Date
2024-08-13
Accepted
2024-08-13 16:00:10
Documents
13
Period of Report
2024-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rphm-20240813.htm   iXBRL 8-K 65319
2 EX-99.1 rphm-ex99_1.htm EX-99.1 262661
3 GRAPHIC img187185602_0.jpg GRAPHIC 15196
  Complete submission text file 0000950170-24-096127.txt   495950

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rphm-20240813.xsd EX-101.SCH 32119
15 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20240813_htm.xml XML 4890
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 241201176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)